# Eptifibatide and ST Segment Resolution Following Primary PCI

> **NCT00812435** · PHASE3 · TERMINATED · sponsor: **Medstar Health Research Institute** · enrollment: 22 (actual)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** eptifibitide

## Key facts

- **NCT ID:** NCT00812435
- **Lead sponsor:** Medstar Health Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-08
- **Primary completion:** 2010-07
- **Final completion:** 2011-03
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2014-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00812435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00812435, "Eptifibatide and ST Segment Resolution Following Primary PCI". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00812435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*